Gilead's remdesivir shows modest improvement in moderate COVID-19 patients

  • 📰 ChannelNewsAsia
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 66%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

FOSTER CITY, California: Gilead Sciences Inc on Monday (Jun 1) reported that its antiviral drug remdesivir provided a modest benefit in patients ...

FOSTER CITY, California: Gilead Sciences Inc on Monday reported that its antiviral drug remdesivir provided a modest benefit in patients with moderate COVID-19 given a five-day course of the treatment, while those who received the medicine for 10 days in the study did not fare as well.

At day 11, around 76 per cent of the patients in the 5-day treatment group showed improvement in clinical status versus 66 per cent for standard care alone, Gilead said. Remdesivir is being closely watched after the US Food and Drug Administration granted emergency use authorization last month, citing results from a US government study that showed the drug reduced hospitalization stays by 31 per cent, or about four days, compared to a placebo.

There are currently no treatments with US approval or vaccines for the new coronavirus that has infected more than 6 million people and killed nearly 373,000 worldwide, including over 104,000 US deaths.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 6. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

South Korea's Celltrion says Covid-19 drug shows drop in viral load in animal testingSEOUL (REUTERS) - South Korea's Celltrion Inc said on Monday (June 1) its experimental treatment of Covid-19 demonstrated a 100-fold reduction in viral load of the disease in animal testing.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

South Korea's Celltrion says COVID-19 drug shows drop in viral load in animal testingSouth Korea's Celltrion Inc said on Monday its experimental treatment of COVID-19 demonstrated a 100-fold reduction in viral load of the disease ...
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

End of Covid-19 circuit breaker: A guide to what you can do from June 2Find out the answers to frequently asked questions about the post-circuit breaker period, as well as information on which services and facilities will be reopening.. Read more at straitstimes.com.
Source: The Straits Times - 🏆 8. / 63 Read more »

Parkway Parade added to list of public places visited by COVID-19 cases while infectiousSINGAPORE: Parkway Parade was on Sunday (May 31) added to a list of public places visited by COVID-19 cases during their infectious period. As ... 😱
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »

Police investigating 3 cases of falsified documents submitted for Covid-19 Support Grant: Desmond LeeSINGAPORE — The Ministry of Social and Family Development (MSF) has uncovered three cases of falsified documents while processing applications for the Covid-19 Support Grant.
Source: TODAYonline - 🏆 1. / 99 Read more »

Thailand reports 4 new COVID-19 cases, no new deathsThailand reported four new coronavirus cases on Sunday and no new deaths, taking the total number of infections to 3,081 with 57 deaths since January.
Source: ChannelNewsAsia - 🏆 6. / 66 Read more »